Hemab Therapeutics Holdings, Inc. (COAG)
NASDAQ: COAG · Real-Time Price · USD
29.24
0.00 (0.00%)
Jun 18, 2026, 4:00 PM EDT - Market closed
COAG Market Cap
COAG has a market cap or net worth of $1.29 billion as of June 18, 2026.
Market Cap
1.29B
Enterprise Value
1.11B
1-Year Change
n/a
Ranking
Category
Stock Price
$29.24
Market Cap Chart
Since the IPO on May 1, 2026, COAG's market cap has increased from $763.97M to $1.29B, an increase of 69.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 1.29B | 10.55% |
| Jun 17, 2026 | 1.17B | 3.68% |
| Jun 16, 2026 | 1.13B | 1.71% |
| Jun 15, 2026 | 1.11B | 0.40% |
| Jun 12, 2026 | 1.10B | -7.28% |
| Jun 11, 2026 | 1.19B | 5.44% |
| Jun 10, 2026 | 1.13B | -5.37% |
| Jun 9, 2026 | 1.19B | 5.68% |
| Jun 8, 2026 | 1.13B | 0.99% |
| Jun 5, 2026 | 1.12B | -0.43% |
| Jun 4, 2026 | 1.12B | -2.90% |
| Jun 3, 2026 | 1.16B | -4.73% |
| Jun 2, 2026 | 1.21B | 1.25% |
| Jun 1, 2026 | 1.20B | -4.81% |
| May 29, 2026 | 1.26B | 1.79% |
| May 28, 2026 | 1.24B | -2.10% |
| May 27, 2026 | 1.26B | 2.73% |
| May 26, 2026 | 1.23B | 7.53% |
| May 22, 2026 | 1.14B | -1.56% |
| May 21, 2026 | 1.16B | -0.64% |
| May 20, 2026 | 1.17B | 4.05% |
| May 19, 2026 | 1.12B | -6.30% |
| May 18, 2026 | 1.20B | -3.28% |
| May 15, 2026 | 1.24B | -1.06% |
| May 14, 2026 | 1.25B | -0.67% |
| May 13, 2026 | 1.26B | 10.27% |
| May 12, 2026 | 1.14B | 3.60% |
| May 11, 2026 | 1.10B | -0.48% |
| May 8, 2026 | 1.11B | -2.41% |
| May 7, 2026 | 1.14B | 2.92% |
| May 6, 2026 | 1.11B | 0.04% |
| May 5, 2026 | 1.10B | -1.34% |
| May 4, 2026 | 1.12B | 46.58% |
| May 1, 2026 | 763.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Savara | 1.39B |
| Inhibrx Biosciences | 1.37B |
| Maravai LifeSciences Holdings | 1.34B |
| Immatics | 1.34B |
| Aktis Oncology | 1.33B |
| Avalyn Pharma | 1.31B |
| MapLight Therapeutics | 1.31B |
| Damora Therapeutics | 1.31B |